Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.

Maghsoomi, Zohreh; Emami, Zahra; Malboosbaf, Ramin; Malek, Mojtaba; Khamseh, Mohammad E

Maghsoomi, Zohreh; Emami, Zahra; Malboosbaf, Ramin; Malek, Mojtaba; Khamseh, Mohammad E.

Affiliation

Maghsoomi Z; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science (IUMS), No. 10, Firoozeh St, Vali-asr Ave, Vali-asr Sq, Tehran, 1593716615, Iran.
Emami Z; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science (IUMS), No. 10, Firoozeh St, Vali-asr Ave, Vali-asr Sq, Tehran, 1593716615, Iran.
Malboosbaf R; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science (IUMS), No. 10, Firoozeh St, Vali-asr Ave, Vali-asr Sq, Tehran, 1593716615, Iran.
Malek M; Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Khamseh ME; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Science (IUMS), No. 10, Firoozeh St, Vali-asr Ave, Vali-asr Sq, Tehran, 1593716615, Iran. khamseh.m@iums.ac.ir.

BMC Cancer ; 21(1): 579, 2021 May 20.

Article in En | MEDLINE | ID: mdl-34016077

Subject(s)

Carcinoma, Neuroendocrine/radiotherapy; Iodine Radioisotopes/administration & dosage; Radiation Injuries/epidemiology; Radiopharmaceuticals/administration & dosage; Thyroid Neoplasms/radiotherapy; Carcinoma, Neuroendocrine/diagnosis; Carcinoma, Neuroendocrine/secondary; Hematologic Diseases/epidemiology; Hematologic Diseases/etiology; Humans; Iodine Radioisotopes/adverse effects; Octreotide/administration & dosage; Octreotide/adverse effects; Octreotide/analogs & derivatives; Organometallic Compounds/administration & dosage; Organometallic Compounds/adverse effects; Radiation Injuries/etiology; Radiation Tolerance; Radiopharmaceuticals/adverse effects; Renal Insufficiency/epidemiology; Renal Insufficiency/etiology; Thyroid Neoplasms/diagnosis; Thyroid Neoplasms/pathology; Thyroid Neoplasms/secondary; Treatment Outcome; Yttrium Radioisotopes/administration & dosage; Yttrium Radioisotopes/adverse effects

Key words

177Lu-DOTATATE; Indium-111; Medullary thyroid carcinoma; Papillary thyroid carcinoma; Peptide receptor radionuclide therapy; Radioiodine refractory-differentiated thyroid Cancer; Systematic review; Yttrium-90

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Radiation Injuries / Thyroid Neoplasms / Carcinoma, Neuroendocrine / Radiopharmaceuticals / Iodine Radioisotopes Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Iran

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google